1. Home
  2. PHGE vs ASTC Comparison

PHGE vs ASTC Comparison

Compare PHGE & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • ASTC
  • Stock Information
  • Founded
  • PHGE 2015
  • ASTC 1984
  • Country
  • PHGE Israel
  • ASTC United States
  • Employees
  • PHGE N/A
  • ASTC N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PHGE Health Care
  • ASTC Industrials
  • Exchange
  • PHGE Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • PHGE 13.3M
  • ASTC 11.0M
  • IPO Year
  • PHGE N/A
  • ASTC 1995
  • Fundamental
  • Price
  • PHGE $0.63
  • ASTC $6.27
  • Analyst Decision
  • PHGE Strong Buy
  • ASTC
  • Analyst Count
  • PHGE 2
  • ASTC 0
  • Target Price
  • PHGE $23.00
  • ASTC N/A
  • AVG Volume (30 Days)
  • PHGE 117.4K
  • ASTC 2.1K
  • Earning Date
  • PHGE 05-19-2025
  • ASTC 05-12-2025
  • Dividend Yield
  • PHGE N/A
  • ASTC N/A
  • EPS Growth
  • PHGE N/A
  • ASTC N/A
  • EPS
  • PHGE N/A
  • ASTC N/A
  • Revenue
  • PHGE N/A
  • ASTC $419,000.00
  • Revenue This Year
  • PHGE N/A
  • ASTC N/A
  • Revenue Next Year
  • PHGE N/A
  • ASTC N/A
  • P/E Ratio
  • PHGE N/A
  • ASTC N/A
  • Revenue Growth
  • PHGE N/A
  • ASTC N/A
  • 52 Week Low
  • PHGE $0.48
  • ASTC $6.04
  • 52 Week High
  • PHGE $4.99
  • ASTC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 49.87
  • ASTC 44.69
  • Support Level
  • PHGE $0.48
  • ASTC $6.19
  • Resistance Level
  • PHGE $0.58
  • ASTC $6.53
  • Average True Range (ATR)
  • PHGE 0.06
  • ASTC 0.16
  • MACD
  • PHGE 0.00
  • ASTC 0.00
  • Stochastic Oscillator
  • PHGE 68.16
  • ASTC 22.22

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: